Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
Taiwan begins requiring civil servants to report travel to Hong Kong, Macau
09/12/2025 11:09 AM - Business
U.S. dollar lower in Taipei trading
09/12/2025 10:31 AM - Business
Taiwan shares open higher
09/12/2025 09:13 AM - Cross-Strait
Apex Aviation confirms China military jet buzzed medevac plane in June
09/11/2025 10:40 PM - Politics